United Kingdom: Food, Drugs, Healthcare, Life Sciences

The UK's new advertising restrictions on less healthy food and drink products came into force in January, and the Advertising Standards Authority has now issued its first enforcement decisions. These rulings against Iceland, Lidl, German Doner Kebab and On The Beach reveal critical compliance lessons for brands navigating nutrient profiling requirements, supply chain responsibilities, and the boundaries of incidental food appearances in digital advertising.

The UK's Advertising Standards Authority has issued its first four rulings under new regulations restricting advertisements for "less healthy" food and drink products, offering crucial guidance on how these rules will be interpreted and enforced. These decisions reveal which promotional tactics pass muster and which cross the line, with implications for food brands, retailers, and influencers navigating the complex Nutrient Profiling Model requirements. The rulings demonstrate that while some food advertisi

The ASA and CAP's Annual Report 2025 reveals a fundamental transformation in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps across multiple sectors while signaling an era of unprecedented data-driven scrutiny.

This report examines critical commercial, legal and regulatory challenges facing life sciences and healthcare companies globally, from shareholder activism and AI-powered drug...

Assays used in clinical trials vary widely in complexity and regulatory status.. They may be fully developed and marketed as in vitro diagnostic medical devices (IVDs), including companion diagnostics (CDx)...

The Court of Appeal has delivered a notable judgment on the interpretation of term and termination provisions in intellectual property licence agreements.

This report examines critical commercial, legal and regulatory challenges facing life sciences and healthcare companies globally, from shareholder activism and AI-powered drug...

The ASA and CAP's Annual Report 2025 reveals a fundamental transformation in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps across multiple sectors while signaling an era of unprecedented data-driven scrutiny.

In a recent LSIPR article published for World Health Day 2026, the spotlight is on the growing momentum in women’s health innovation, and the persistent gaps that still hamper progress.